{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:53:16Z","timestamp":1789912396561,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ygyno.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T19:12:05Z","timestamp":1741461125000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcoma"],"prefix":"10.1016","volume":"195","author":[{"given":"Kevin","family":"Tyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin X.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia C.","family":"Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Feltmate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil S.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Michael J.","family":"Worley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce F.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexi A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis A.","family":"Konstantinopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana M.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula A.","family":"Matulonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idalid","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin T.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Aiven","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2025.03.004_bb0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/GRF.0b013e31821ac635","article-title":"Uterine carcinosarcoma","volume":"54","author":"El-Nashar","year":"2011","journal-title":"Clin. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.004_bb0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ygyno.2020.04.683","volume":"158","author":"Elshaikh","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.004_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00004347-199501000-00007","article-title":"Malignant mixed Mullerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival","volume":"14","author":"George","year":"1995","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.004_bb0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004347-199004000-00004","article-title":"Prognostic factors for malignant mixed m\u00fcllerian tumors of the uterus","volume":"9","author":"Schweizer","year":"1990","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.004_bb0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0090-8258(89)90176-5","article-title":"Clinicopathologic analysis of uterine malignant mixed m\u00fcllerian tumors","volume":"34","author":"Nielsen","year":"1989","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.004_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ygyno.2008.06.035","article-title":"A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I\u2013IV uterine carcinosarcoma","volume":"111","author":"Makker","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"S4","key":"10.1016\/j.ygyno.2025.03.004_bb0035","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/cncr.2820710440","article-title":"Prognostic factors in early-stage uterine sarcoma: a gynecologic oncology group study","volume":"71","author":"Major","year":"1993","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.004_bb0040","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1186\/s12885-019-5879-7","article-title":"Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study","volume":"19","author":"Li","year":"2019","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2025.03.004_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123573","article-title":"The role of postoperative radiotherapy for carcinosarcoma of the uterus","volume":"12","author":"Vordermark","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.004_bb0050","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(99)00427-7","article-title":"High-dose-rate postoperative vaginal cuff irradiation alone for stage Ib and Ic endometrial cancer","volume":"46","author":"Anderson","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9717","key":"10.1016\/j.ygyno.2025.03.004_bb0055","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ygyno.2025.03.004_bb0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.brachy.2015.06.003","article-title":"Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcoma","volume":"14","author":"Patel","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2025.03.004_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/124149","article-title":"Uterine carcinosarcoma confined to the pelvis: a retrospective review and outcome analysis","volume":"2014","author":"Li","year":"2014","journal-title":"J. Radiother."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.004_bb0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brachy.2017.09.011","article-title":"Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: a National Cancer Database analysis","volume":"17","author":"Stokes","year":"2018","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.004_bb0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/igc.0000000000001135","article-title":"Role of radiation therapy in the multidisciplinary management of uterine carcinosarcoma","volume":"28","author":"Gunther","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.004_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IGC.0000000000000561","article-title":"The impact of adjuvant therapy on survival and recurrence patterns in women with early-stage uterine carcinosarcoma: a multi-institutional study","volume":"26","author":"Guttmann","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.004_bb0085","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.brachy.2019.04.200","article-title":"Adjuvant vaginal cuff brachytherapy and patterns of failure for early stage uterine carcinosarcoma","volume":"18","author":"Zhu","year":"2019","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.ygyno.2025.03.004_bb0090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.brachy.2015.02.194","article-title":"Vaginal brachytherapy for early-stage carcinosarcoma of the uterus","volume":"14","author":"Brown","year":"2015","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.004_bb0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.prro.2019.11.004","article-title":"Low-dose adjuvant cylinder brachytherapy for endometrioid endometrial cancer","volume":"10","author":"Alban","year":"2020","journal-title":"Pract. Radiat. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2025.03.004_bb0100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/COC.0000000000000360","article-title":"Chemoradiation versus chemotherapy in uterine carcinosarcoma: patterns of care and impact on overall survival","volume":"41","author":"Odei","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.004_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2012.06.020","article-title":"A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma","volume":"127","author":"Cantrell","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.004_bb0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejca.2020.04.012","article-title":"Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study","volume":"133","author":"van Weelden","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2025.03.004_bb0115","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1136\/ijgc-2020-001623","article-title":"Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes","volume":"30","author":"Smart","year":"2020","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:22:07Z","timestamp":1777641727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825000733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":23,"alternative-id":["S0090825825000733"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.03.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}